RankingsPricing
  1. US-listed companies
  2. Teladoc Health, Inc.
  3. Financials
  4. Cash from investing

Teladoc Health, Inc.TDOC

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-124-20.66%
Dec 31, 2023-156-6.79%
Dec 31, 2022-168+129.84%
Dec 31, 2021-73-87.65%
Dec 31, 2020-591-2462.67%
Dec 31, 201925-109.71%
Dec 31, 2018-257-42.57%
Dec 31, 2017-448-1814.90%
Dec 31, 201626-124.16%
Dec 31, 2015-108

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)